{"id":"https://openalex.org/W3097014108","doi":"https://doi.org/10.1182/blood-2020-136625","title":"Comparative Efficacy of CC-486 Versus Injectable Azacitidine (AZA) in Patients (Pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy: Findings from an Indirect Treatment Comparison (ITC)","display_name":"Comparative Efficacy of CC-486 Versus Injectable Azacitidine (AZA) in Patients (Pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy: Findings from an Indirect Treatment Comparison (ITC)","publication_year":2020,"publication_date":"2020-11-04","ids":{"openalex":"https://openalex.org/W3097014108","doi":"https://doi.org/10.1182/blood-2020-136625","mag":"3097014108"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-136625","doi":"https://doi.org/10.1182/blood-2020-136625","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-136625","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103581365","display_name":"Clara C. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clara Chen","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039372176","display_name":"Timothy C. Disher","orcid":"https://orcid.org/0000-0002-1032-2252","observed_orcids":["https://orcid.org/0000-0002-1032-2252"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Tim Disher","raw_affiliation_strings":["EVERSANA, Burlington, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032526001","display_name":"Muhaimen Siddiqui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Muhaimen Siddiqui","raw_affiliation_strings":["EVERSANA, Burlington, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064895172","display_name":"Ignazia La Torre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ignazia La Torre","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111658759","display_name":"Barry Skikne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry Skikne","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ","Kansas University Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Kansas University Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001617887","display_name":"Beatrice Suero","orcid":"https://orcid.org/0009-0009-3134-5136","observed_orcids":["https://orcid.org/0009-0009-3134-5136"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Beatrice Suero","raw_affiliation_strings":["EVERSANA, Burlington, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024264093","display_name":"Heather L. Cameron","orcid":"https://orcid.org/0000-0002-3886-8257","observed_orcids":["https://orcid.org/0000-0002-3886-8257"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Heather Cameron","raw_affiliation_strings":["EVERSANA, Burlington, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010731242","display_name":"Roya Gavanji","orcid":"https://orcid.org/0000-0002-7182-6577","observed_orcids":["https://orcid.org/0000-0002-7182-6577"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Roya Gavanji","raw_affiliation_strings":["EVERSANA, Burlington, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065455132","display_name":"Chris G Cameron","orcid":"https://orcid.org/0000-0003-3613-760X","observed_orcids":["https://orcid.org/0000-0003-3613-760X"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Chris Cameron","raw_affiliation_strings":["EVERSANA, Burlington, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, Canada","institution_ids":["https://openalex.org/I4210153140"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"136","issue":"Supplement 1","first_page":"23","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cc-486","display_name":"CC-486","score":0.9620000123977661},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.8730000257492065},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9200000166893005},{"id":"https://openalex.org/keywords/first-complete-remission","display_name":"first complete remission","score":0.7730000019073486},{"id":"https://openalex.org/keywords/intensive-induction-chemotherapy","display_name":"intensive induction chemotherapy","score":0.9049999713897705},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8560000061988831},{"id":"https://openalex.org/keywords/indirect-treatment-comparison","display_name":"indirect treatment comparison","score":0.8870000243186951},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.492000013589859},{"id":"https://openalex.org/keywords/individual-patient-data","display_name":"individual patient data","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7757307291030884},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6089565753936768},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5644785761833191},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.5397613048553467},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.5317814350128174},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.47211897373199463},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4361391067504883},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35163170099258423},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3458007276058197},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-136625","doi":"https://doi.org/10.1182/blood-2020-136625","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-136625","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3095309665","https://openalex.org/W2989764345","https://openalex.org/W2600516765","https://openalex.org/W3114952208","https://openalex.org/W3211747437","https://openalex.org/W2999169540","https://openalex.org/W3032335069","https://openalex.org/W3032582141","https://openalex.org/W2593191135","https://openalex.org/W3211546201"],"abstract_inverted_index":{"Introduction:":[0],"Standard":[1],"treatment":[2,145,684],"with":[3,10,36,45,53,95,121,166,402,431,468,547,566,622,626,673,685,693,699],"intensive":[4,59,127,172],"induction":[5],"chemotherapy":[6,60,128],"(IC)":[7],"for":[8,119,282,363,370,397,537,601],"pts":[9,24,44,120,165,232,239],"AML":[11,46,122,167],"can":[12],"induce":[13],"remission,":[14],"but":[15],"responses":[16],"are":[17],"often":[18],"short-lived,":[19],"and":[20,110,202,214,272,311,336,406,421,436,470,478,485,490,493,510,533,536,570,574,585,596,600,610,651,654,681],"the":[21,85,136,153,193,234,241,261,264,273,278,283,305,308,324,327,350,353,357,360,371,381,385,447,464,511,516,538,602,627,694],"majority":[22],"of":[23,101,138,156,198,205,352,359,384,414,442,619,646],"will":[25],"relapse":[26],"(Chen":[27],"Y,":[28],"et":[29,63,69,131,224,288],"al.":[30,64,70,132,225,289],"Medicine":[31],"2016;95:e4182).":[32],"Although":[33],"maintenance":[34,93,162,683],"therapy":[35,94,163,248],"injectable":[37,159,206,649],"AZA":[38,160,207,432,443,471,543,571,650],"has":[39],"improved":[40],"disease-free":[41],"survival":[42,75,302,318,374,500,526,564,679,690],"in":[43,47,108,114,123,164,168,240,263,433,446,524,555,616,634,677,711,729,756],"complete":[48],"remission":[49,170],"(CR)":[50],"or":[51,457,558],"CR":[52],"incomplete":[54],"hematologic":[55],"recovery":[56],"(CRi)":[57],"after":[58,171],"(Huls":[61],"G,":[62],"Blood":[65,71,133],"2019;133:1457;":[66],"Oliva":[67],"EN,":[68],"2019;134(Supp":[72],"1):117),":[73],"overall":[74],"(OS)":[76],"benefits":[77,550],"have":[78],"been":[79],"more":[80,655],"difficult":[81],"to":[82,143,151,304,409,452,456,504],"achieve.":[83],"In":[84,135,638],"randomized,":[86],"phase":[87],"3":[88,579],"QUAZAR":[89,194,398,635],"AML-001":[90,195,399],"study":[91,197],"(NCT01757535),":[92],"CC-486,":[96],"a":[97,104,111,419,520,643,674,688],"novel":[98],"oral":[99],"formulation":[100],"AZA,":[102],"demonstrated":[103],"significant":[105,548],"9.9-month":[106],"improvement":[107,523,615,630,676],"OS":[109,176,190,255,266,280,328,425,466,549,618,629,658],"31%":[112],"reduction":[113],"mortality":[115],"versus":[116,158,200,208,444,568,576,583,594,608],"placebo":[117],"(PBO)":[118],"first":[124,169],"CR/CRi":[125],"following":[126],"(Wei":[129],"AH,":[130],"2019;134:LBA-3).":[134],"absence":[137],"direct":[139],"head-to-head":[140],"clinical":[141],"studies":[142,204],"guide":[144],"selection,":[146],"we":[147],"used":[148],"an":[149,652],"ITC":[150],"evaluate":[152],"comparative":[154],"efficacy":[155],"CC-486":[157,199,417,469,518,567,623,641,670,686],"as":[161,323],"chemotherapy.":[173],"Methods:":[174],"Relative":[175],"was":[177,257,297,321,343,376,395,475,544,581,592,606,624,661,671],"calculated":[178,258],"by":[179,259,277,299,348],"using":[180,218,389],"individual":[181],"patient":[182],"data":[183],"(IPD)":[184],"derived":[185],"from":[186,192,233,307,356,380,506],"published":[187],"Kaplan-Meier":[188],"(KM)":[189],"curves":[191,303,501],"(NCT01757535)":[196],"PBO,":[201],"2":[203],"control":[209,445,577],"(HOVON":[210,472,572],"97":[211,405,435,557,573],"[EudraCT":[212,216],"2008-001290-15]":[213],"QoLESS":[215,407,437,559],"2010-019710-24])":[217],"Engauge":[219],"digitization":[220],"software":[221],"(Guyot":[222],"P,":[223],"BMC":[226],"Med":[227],"Res":[228],"Methodol":[229],"2012;12:9).":[230],"Unlike":[231],"intervention":[235,270,309,361,508],"arm":[236,243,271,276,285,310,355,362,509],"(CC-486,":[237],"AZA),":[238],"PBO/control":[242,275,284,312,354,513],"did":[244],"not":[245,545],"receive":[246],"cancer":[247],"post-IC.":[249],"For":[250],"each":[251,269,364,507],"study,":[252],"time-specific":[253],"relative":[254,424,440,465,657,695],"benefit":[256,426,441,467,565,691,697],"dividing":[260],"difference":[262],"KM":[265,279],"estimate":[267,281],"between":[268],"respective":[274,512],"(Betts":[286],"KA,":[287],"poster":[290],"presented":[291],"at":[292,331,345,412,480,487,495,528,551,578,589],"EHA":[293],"2017:E1300).":[294],"Treatment":[295],"effect":[296],"measured":[298],"fitting":[300],"parametric":[301,387],"IPD":[306,505],"arms,":[313],"respectively.":[314,498,613],"The":[315,339,439,561,614],"restricted":[316],"mean":[317,373,525,562,617,678],"time":[319,375,413,527,553],"(RMST)":[320],"estimated":[322,377],"area":[325],"under":[326],"curve":[329],"(AUC)":[330],"1,":[332,529],"2,":[333,530],"3,":[334,531],"4,":[335,532],"5":[337,534,590],"years.":[338],"incremental":[340,372,563],"AUC":[341],"(\u0394AUC)":[342],"determined":[344],"selected":[346],"timepoints":[347],"subtracting":[349],"RMST":[351,358],"study.":[365],"A":[366],"95%":[367],"confidence":[368],"interval":[369],"via":[378],"simulation":[379],"variance-covariance":[382],"matrix":[383],"fitted":[386,503],"model":[388],"\u2265":[390],"10,000":[391],"iterations.":[392],"Results:":[393],"Follow-up":[394],"longest":[396],"(5":[400],"years)":[401],"both":[403],"HOVON":[404,434,556],"limited":[408],"30":[410],"months":[411,429,450,621],"analysis.":[415],"Overall,":[416],"showed":[418,519],"sustained":[420],"numerically":[422],"higher":[423],"through":[427],"60":[428,664],"compared":[430,692],"(Figure).":[438],"initial":[448],"18":[449,488],"appeared":[451],"fade,":[453],"reaching":[454],"close":[455],"below":[458],"zero":[459],"around":[460],"month":[461],"21.":[462],"Indeed,":[463],"97,":[473],"QoLESS)":[474,575],"30.4%,":[476],"20.3%,":[477],"15.5%":[479],"12":[481],"months;":[482,489],"35.5%,":[483],"17.0%,":[484],"21.8%":[486],"36.4%,":[491],"\u22127.7%,":[492],"2.2%":[494],"24":[496],"months,":[497,587,598,612],"Log-normal":[499],"were":[502],"arm.":[514],"Comparing":[515],"RMST,":[517],"statistically":[521],"meaningful":[522,675],"years":[535,580,591],"entire":[539,603],"extrapolation":[540,604],"period,":[541],"while":[542],"associated":[546,672],"any":[552],"point":[554],"(Table).":[560],"PBO":[569],"4.18":[582],"1.18":[584],"2.35":[586],"respectively;":[588,599],"6.14":[593],"1.11":[595],"0.99":[597],"period":[605],"10.12":[607,620],"\u22126.58":[609],"\u221218.32":[611],"consistent":[625],"median":[628],"(9.9":[631],"months)":[632],"reported":[633],"AML-001.":[636],"Conclusions:":[637],"this":[639],"ITC,":[640],"had":[642],"longer":[644],"duration":[645],"follow-up":[647],"than":[648],"earlier":[653],"durable":[656],"benefit,":[659],"which":[660],"maintained":[662],"beyond":[663],"months.":[665],"This":[666],"analysis":[667],"demonstrates":[668],"that":[669,682],"time,":[680],"provides":[687],"long-term":[689],"short-term":[696],"observed":[698],"AZA.":[700],"Disclosures":[701],"Chen:":[702],"Bristol":[703,740],"Myers":[704,722,733,741],"Squibb:":[705,723,734,742],"Current":[706,708,715,718,724,726,735,738,745,748,751,753],"Employment,":[707,725,752],"equity":[709,727,754],"holder":[710,728,755],"publicly-traded":[712,730],"company.":[713,731,758],"Disher:Eversana:":[714],"Employment.":[716,719,736,746,749],"Siddiqui:Eversana:":[717],"La":[720],"Torre:Bristol":[721],"Skikne:Bristol":[732],"Suero:Eversana:":[737],"Employment;":[739],"Consultancy.":[743],"Cameron:Eversana:":[744,750],"Gavanji:Eversana:":[747],"private":[757]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2020-11-09T00:00:00"}